Tolcher, A.W.

A phase Ib/II study of APG-115 in combination with pembrolizumab in patients with unresectable or metastatic melanomas or advanced solid tumors

Tolcher, A. W., Fang, D. D., Li, Y., Tang, Y., Ji, J., Wang, H., Karim, R., Rosas, C., Huang, Y., & Zhai, Y. (2019) · Annals of Oncology

Cancer Immunotherapy and BiomarkersCancer-related Molecular Pathways

Cited by 13

1660TiP First-in-human study of ABBV-969, a dual variable antibody-drug conjugate (ADC), in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC)

Berger, R., Tolcher, A. W., Dorff, T. B., Okubo, S., Abraham, L. S., Reilly, R., Stevenson, C., Wang, S., Arnold, J., Mudd, S. R., et al. (2024) · Annals of Oncology

Prostate Cancer Treatment and ResearchProtein Degradation and Inhibitors

Cited by 8